Brief: Novan Announces Strategic Priorities And Outlines Key Milestones

NVN Liquidation

09/09/2021 13:13

Sept 9 (Reuters) - Novan Inc  NOVN.O :
    * NOVAN ANNOUNCES STRATEGIC PRIORITIES AND OUTLINES KEY
MILESTONES
    * NOVAN INC - PLANNING FOR THREE POTENTIAL NEW DRUG
APPLICATION
(NDA) FILINGS IN THREE YEARS
    * NOVAN INC - FIRST NDA SUBMISSION EXPECTED IN Q3 2022 FOR
LEAD
PROGRAM SB206 IN MOLLUSCUM CONTAGIOSUM
    * NOVAN INC - SB019 SARS-COV-2 DEVELOPMENT PROGRAM ADVANCING
TOWARD PHASE 1 STUDY IN HEALTHY VOLUNTEERS, TARGETED FOR 1H 2022

Source text for Eikon:  ID:nGNX6r1NhC 
Further company coverage:  NOVN.O 

 ((Reuters.Briefs@thomsonreuters.com;))